Literature DB >> 9450669

Prevention of lens protein glycation by taurine.

P S Devamanoharan1, A H Ali, S D Varma.   

Abstract

Modifications in lens protein structure and function due to nonenzymic glycosylation and oxidation have been suggested to play a significant role in the pathogenesis of sugar and senile cataracts. The glycation reaction involves an initial Schiff base formation between the protein NH2 groups and the carbonyl group of a reducing sugar. The Schiff base then undergoes several structural modifications, via some oxidative reactions involving oxygen free radicals. Hence certain endogenous tissue components that may inhibit the formation of protein-sugar adduct formation may have a sparing effect against the cataractogenic effects of sugars and reactive oxygen. The eye lens is endowed with significant concentration of taurine, a sulfonated amino acid, and its precursor hypotaurine. It is hypothesized that taurine and hypotaurine may have this purported function of protecting the lens proteins against glycation and subsequent denaturation, in addition to their other functions. The results presented herein suggest that these compounds are indeed capable of protecting glycation competitively by forming Schiff bases with sugar carbonyls, and thereby preventing the glycation of lens proteins per se. In addition, they appear to prevent oxidative damage by scavenging hydroxyl radicals. This was apparent by their preventive effect against the formation of the thiobarbituric acid reactive material generated from deoxy-ribose, when the later was exposed to hydroxyl radicals generated by the action of xanthine oxidase on hypoxanthine in presence of iron.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9450669     DOI: 10.1023/a:1006863322454

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Flavonoids as inhibitors of lens aldose reductase.

Authors:  S D Varma; I Mikuni; J H Kinoshita
Journal:  Science       Date:  1975-06-20       Impact factor: 47.728

2.  Studies on intraocular transport of taurine. II. Accumulation in the rabbit lens.

Authors:  V N Reddy
Journal:  Invest Ophthalmol       Date:  1970-03

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro.

Authors:  P Ou; S P Wolff
Journal:  Biochem Pharmacol       Date:  1993-10-05       Impact factor: 5.858

5.  Formation of thiobarbituric-acid-reactive substance from deoxyribose in the presence of iron salts: the role of superoxide and hydroxyl radicals.

Authors:  B Halliwell; J M Gutteridge
Journal:  FEBS Lett       Date:  1981-06-15       Impact factor: 4.124

6.  A physiological level of ascorbate inhibits galactose cataract in guinea pigs by decreasing polyol accumulation in the lens epithelium: a dehydroascorbate-linked mechanism.

Authors:  T Yokoyama; H Sasaki; F J Giblin; V N Reddy
Journal:  Exp Eye Res       Date:  1994-02       Impact factor: 3.467

7.  Diabetic cataracts and flavonoids.

Authors:  S D Varma; A Mizuno; J H Kinoshita
Journal:  Science       Date:  1977-01-14       Impact factor: 47.728

8.  Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.

Authors:  M Datiles; H Fukui; T Kuwabara; J H Kinoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-02       Impact factor: 4.799

9.  Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats.

Authors:  R E Perry; M S Swamy; E C Abraham
Journal:  Exp Eye Res       Date:  1987-02       Impact factor: 3.467

10.  Flavonoids are scavengers of superoxide anions.

Authors:  J Robak; R J Gryglewski
Journal:  Biochem Pharmacol       Date:  1988-03-01       Impact factor: 5.858

View more
  6 in total

Review 1.  Revisiting amino acids and peptides as anti-glycation agents.

Authors:  H Chilukuri; M J Kulkarni; M Fernandes
Journal:  Medchemcomm       Date:  2018-02-12       Impact factor: 3.597

Review 2.  Ameliorative effects of taurine against diabetes: a review.

Authors:  Fengyuan Piao; Rana Muhammad Aadil; Raheel Suleman; Kaixin Li; Mengren Zhang; Pingan Wu; Muhammad Shahbaz; Zulfiqar Ahmed
Journal:  Amino Acids       Date:  2018-02-28       Impact factor: 3.520

3.  Traditional reactive carbonyl scavengers do not prevent the carbonylation of brain proteins induced by acute glutathione depletion.

Authors:  J Zheng; O A Bizzozero
Journal:  Free Radic Res       Date:  2010-03

Review 4.  Is taurine beneficial in reducing risk factors for diabetes mellitus?

Authors:  Flavia Franconi; Mauro A S Di Leo; Federico Bennardini; Giovanni Ghirlanda
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 5.  Age-related retinal degeneration in animal models of aging: possible involvement of taurine deficiency and oxidative stress.

Authors:  Julius Militante; John B Lombardini
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 6.  Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Authors:  Margo P Cohen; Fuad N Ziyadeh; Sheldon Chen
Journal:  J Lab Clin Med       Date:  2006-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.